Veterinary Orthopedic Medicines Industry Overview

The global veterinary orthopedic medicines market size was estimated at USD 1.62 billion in 2023 and is expected to grow at a CAGR of 8.6% from 2024 to 2030.

The growth can be attributed to rising prevalence of orthopedic disorders in animals, the growing uptake of pet insurance, an increase in the aging animal population, and advancements in veterinary orthopedic medicines. Orthopedic issues can negatively impact an animal's quality of life by affecting the bones, muscles, and joints. Canine dysplasia of the elbow hips and arthritis are among common conditions. Several factors contribute to orthopedic problems in animals, including aging, poor diet, and obesity. Recent studies have shown a rise in obesity among animals such as dogs and horses. For instance, an NCBI study in 2023 on horses revealed a 45% obesity rate.

Gather more insights about the market drivers, restrains and growth of the Veterinary Orthopedic Medicines Market

Stem cell therapy has recently gained popularity and generated significant interest in research clinical settings. In veterinary medicine, stem cell therapy has been studied as a potential treatment option for various health complications such as dermatological, orthopedic, dental, etc. The use of stem cells in these diseases is still in its infancy, but the potential for stem cell therapy in veterinary medicine is extensive. For instance, StemcellX, a UK-based company, currently has two stem-cell products in the pipeline for application in dogs and horses. The veterinary orthopedic medicines market is growing due to increase in prevalence of Osteoarthritis (OA) and other Degenerative Joint Diseases (DJD) among various animals like dogs, cats, horses, among others. According to estimates from a 2022 study in Frontiers of Veterinary Sciences, OA is the most common musculoskeletal disorder in dogs, and about 1 in 4 dogs suffer from it. Another research study from the Veterinary Ireland Journal stated that approximately 40% of all cats suffer from OA. Estimates provided by the American Animal Hospital Association (AAHA) reveal that 40% to 92% of cats experience joint pain due to OA or other DJD. Furthermore, the studies suggest possible underdiagnosis of these conditions in these animals. Figures provided by Zoetis indicate that out of the total diagnosed cases of canine OA in the US, only 33% are treated.

Furthermore, University of Illinois data suggests that athletic horses are at a high risk of developing OA that causes lameness. It is estimated that over 50% of horses older than 15 years suffer from OA, and in horses over 30 years of age, this number increases to more than 80% to 90%. OA affects the performance and wellbeing of athletic horses. For early diagnosis, it is important to understand causal developmental pathways and prescribe the right treatment. Moreover, several pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article in USA Today, 26% of surveyed Americans stated they spend between USD 51 USD 100 a month on their dogs. The same number of people (26%) spend from USD 101 to USD 250 monthly on dog care. Ownership of a dog can cost up to USD 5,000 in some cases. About 66% of the respondents said they had to cut down on their personal expenses to meet the rising costs of owning a pet. Others have taken out loans or asked for financial assistance to pay for the care of animals.

Browse through Grand View Research's Animal Health Industry Research Reports.

• The global livestock monitoring market size was estimated at USD 4.01 billion in 2023 and is anticipated to grow at a CAGR of 11.56% from 2024 to 2030. 
• The North America and Europe exotic companion animal market size was estimated at USD 1.30 billion in 2023 and is projected to grow at a CAGR of 7.9% from 2024 to 2030.

Key Veterinary Orthopedic Medicines Company Insights

Some of the key players operating in the market are Zoetis Inc; Boehringer Ingelheim; Elanco Animal Health, Inc.; and Merck Animal Health (Merck Co. Inc). Industry leaders like Zoetis, Inc.; Boehringer Ingelheim; Elanco Animal Health; American Regent, Inc.; Merck Animal Health (Merck Co. Inc); and Vetoquinol S.A. are investing significantly in the RD of novel medicines for musculoskeletal complications prevalent in various animals. Companies like Ardent Animal Health, LLC; VetStem, Inc.; and MEDREGO LLC are focusing on developing specialized biologics like stem cells, PRP, and other biologics to effectively combat orthopedic conditions in animals.

Zoetis is one of the leading veterinary product companies in the world. It discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, other technologies for the treatment of various diseases in companion animals, as well as livestock animals. It has a widespread network in over 45 countries.

Elanco Animal Health has operated in the veterinary industry for over 65 years. It is a subsidiary of the pharmaceutical products giant Elli Lilly Company. The company is among the top four global veterinary product manufacturers, with over 200 brands and a presence in over 90 countries.

Hyalogic, Bioiberica S.A.U, and Contipro A.S. are some of the emerging market participants in the veterinary orthopedic medicines market.

Hyalogic is a company that specializes in and focuses on manufacturing products made from high-molecular-weight hyaluronic acid, which has hydrating and lubricating properties. Its product portfolio includes skin care, personal care, joint care, etc., for humans and specialized joint care products for animals.

Key Veterinary Orthopedic Medicines Companies:

The following are the leading companies in the veterinary orthopedic medicines market. These companies collectively hold the largest market share and dictate industry trends.

• Zoetis Inc.
• Boehringer Ingelheim
• Elanco Animal Health
• American Regent, Inc.
• Merck Animal Health (Merck Co. Inc)
• Vetoquinol S.A.
• Ceva Sante Animale
• Virbac
• Biogenesis Bago
• Ardent Animal Health, LLC
• Bioiberica S.A.U
• PetVivo Holdings, Inc. (Spryng)
• Contipro A.S.
• VetStem, Inc.
• Enso Discoveries
• Contura Vet US
• T-Cyte Therepeutics
• MEDREGO LLC
• Bimeda U.S.
• Hyalogic
• Hester Biosciences .

Order a free sample PDF of the Veterinary Orthopedic Medicines Market Study, published by Grand View Research.